L-Citrulline for Health & Longevity - Quick Reference Sheet

L-Citrulline for Health & Longevity

Created on 07/10/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 Audit

L-Citrulline is a watermelon-derived amino acid that raises arginine and nitric oxide, relaxing blood vessels. Its most reliable effect is lifting circulating arginine; signals for lower blood pressure, easier vessel widening, less muscle soreness, and modest strength gains are promising but uneven, clearest in older adults with higher blood pressure. Well tolerated; longevity claims stay early. (Full Review)

Protocol

Vascular Dose
3–6 g/day
Pure L-Citrulline, taken consistently
Performance Dose
6–8 g
Citrulline malate, ~60 min pre-training
Split Dosing
2 × 3 g/day
For blood-pressure goals, to sustain arginine
Time to effect
Blood Flow
~1 hour
Acute effect; plasma peaks ~1 h
Blood Pressure
4–8 weeks
Consistent daily use
Endothelial Function
4–8 weeks
Consistent daily use

Benefits

Contraindications
  • Current nitrate use
  • Symptomatic low blood pressure (systolic below 90 mmHg)
  • Inherited urea-cycle disorders (except under specialist care)
  • Severe kidney impairment (eGFR below 30 mL/min/1.73 m²)
  • Scheduled surgery (stop 24–48 h before)
Key Interactions
  • Antihypertensives (ACE inhibitors, ARBs, calcium channel blockers)
  • PDE5 inhibitors (sildenafil, tadalafil)
  • L-Arginine and nitric-oxide supplements
  • Blood-pressure-lowering supplements (nitrate/beetroot, garlic, magnesium, potassium, coenzyme Q10)
  • Over-the-counter nitric-oxide pre-workout products

Risk & Side Effects

  • High: Mild gastrointestinal effects
  • Medium: Additive hypotension and dizziness
  • Low: Nitric-oxide-related headache or flushing
  • Speculative: Unknown long-term safety at high doses; theoretical promotion of viral replication via arginine

Monitoring

Marker Target Why
Blood Pressure <120/80 mmHg Primary target of vascular use
Resting Heart Rate 50–70 bpm Context for cardiovascular status
Flow-Mediated Dilation >7% Direct readout of endothelial function
eGFR (kidney filtration) >90 mL/min/1.73 m² Kidney performs citrulline-to-arginine conversion
BUN 10–16 mg/dL Reflects urea-cycle and kidney handling
Fasting Blood Glucose 70–85 mg/dL Metabolic context; diabetes raises arginase
hs-CRP <1 mg/L General marker of inflammation affecting vessels

Cadence: Blood pressure at 1, 4, and 8 weeks, then every 6–12 months if used long term; kidney and metabolic markers every 6–12 months

Qualitative Assessment

  • Exercise tolerance and muscle fullness
  • Post-exercise soreness
  • Energy and lightheadedness
  • Erectile or circulatory quality